Resynchronisation pacing shows promise in final MUSTIC data
This article was originally published in Clinica
Executive Summary
A multicentre European team claims that data is now available to validate biventricular pacing as a new resynchronisation therapy for patients with severe congestive heart failure (CHF) and major intraventricular conduction delay. However, the findings also appear to suggest that the number of patients who could benefit from the treatment might not be as large as previously thought.